TERUMO CORP revenue for the last year amounted to 111.36 B MXN, the most of which — 65.25 B MXN — came from its highest performing source at the moment, Cardiovascular, the year earlier bringing 64.87 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought TERUMO CORP 33.42 B MXN, and the year before that — 31.27 B MXN.